Join our live webinar, led by leading experts, to explore the latest advancements in treating early-stage and advanced renal cell carcinoma (RCC). Discover the most recent clinical evidence to guide evidence-based, personalized treatment decisions, including the latest clinical trial data on newer adjuvant approaches in RCC. Our specialists will also provide insights into identifying and managing adverse events (AEs) to improve patient outcomes. Don’t miss this opportunity to enhance your knowledge and optimize care for RCC patients in federal, public, and government healthcare settings!
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/virtual/kidney-cancer-current-treatment-approaches-using-targeted-agents-immunotherapy
- Start Date: 2025-05-06 05:00:00
- End Date: 2025-05-06 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.5 hours
AMA PRA Category 1 Credit™️: 0.5 hours
Nursing: 0.5 hours
Pharmacy: 0.5 hours - MOC Credit Details: ABIM - 0.5 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Aveo Pharmaceuticals - Amount: 2083.33 - Is Kind Support: False Source: Merck (Any division) - Amount: 16666.67 - Is Kind Support: False
- Activity Type: Live Course
- CME Finder Type: Conference
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology
Subscribe
Login
0 Comments
Oldest